Recombinant C. difficile Toxin A/TcdA Protein, CF Summary
Product Specifications
msyB (Thr2-Arg124) Accession # P25738 |
GSENLYFQGH | C. difficile TcdA (Met1-Leu542, Arg184Asn) Accession # P16154 |
HHHHHH |
N-terminus | C-terminus | ||
Analysis
Product Datasheets
Carrier Free
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
8619-GT
Formulation | Supplied as a 0.2 μm filtered solution in Tris, NaCl and Glycerol. |
Shipping | The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Assay Procedure
- Glycosyltransferase Activity Kit (Catalog # EA001)
- Assay Buffer: 25 mM Tris, 150 mM NaCl, 10 mM MnCl2, 5 mM CaCl2, 150 mM K2SO4, pH 7.0
- Recombinant C. difficile Toxin A/TcdA (rC.d.TcdA) (Catalog # 8619-GT)
- UDP-Glucose (Calbiochem, Catalog # 670120), 10 mM stock in 25% Ethanol
- 96-well Clear Plate (Catalog # DY990)
- Plate Reader (Model: SpectraMax Plus by Molecular Devices) or equivalent
- Dilute 1 mM Phosphate Standard provided by the Glycosyltransferase Kit by adding 40 µL of the 1 mM Phosphate Standard to 360 µL of Assay Buffer for a 100 µM stock.
- Prepare the standard curve by performing seven one-half serial dilutions of the 100 µM Phosphate stock using Assay Buffer. The standard curve has a range of 0.039 to 2.5 nmol per well.
- Prepare reaction mixture containing 0.8 mM UDP-Glucose and 8 µg/mL Coupling Phosphatase 1 in Assay Buffer.
- Dilute rC.d.TcdA to 40 ng/µL in Assay Buffer.
- Load 50 µL of each dilution of the standard curve into a plate. Include a curve blank containing 50 μL of Assay Buffer.
- Load 25 µL of 40 ng/µL rC.d.TcdA into empty wells of the same plate as the curve. Include a Control containing 25 μL of Assay Buffer.
- Add 25 µL of the reaction mixture to all wells, excluding the standard curve.
- Seal plate and incubate at room temperature for 40 minutes.
- Add 30 µL of the Malachite Green Reagent A to all wells. Mix briefly.
- Add 100 µL of deionized water to all wells. Mix briefly.
- Add 30 µL of the Malachite Green Reagent B to all wells. Mix and incubate sealed plate for 20 minutes at room temperature.
- Read plate at 620 nm (absorbance) in endpoint mode.
- Calculate specific activity:
Specific Activity (pmol/min/µg) = |
Phosphate released* (nmol) x (1000 pmol/nmol) |
Incubation time (min) x amount of enzyme (µg) |
*Derived from the phosphate standard curve using linear or 4-parameter fitting and adjusted for Control
Per Reaction:- rC.d.TcdA: 1 µg
- Coupling Phosphatase 1: 0.2 µg
- UDP-Glucose: 0.4 mM
Reconstitution Calculator
Background: Toxin A/TcdA
Clostridium difficile is the leading cause of hospital-acquired diarrhea, known as C. difficile-associated disease (1, 2). The major virulence factors produced by C. difficile are two toxins, TcdA and TcdB. Both toxins can monoglucosylate and inactivate Rho family small GTPases within target cells, leading to disruption of vital signaling pathways in the cell, subsequently causing diarrhea, inflammation, and damage of colonic mucosa (3 4, 5). Both toxins have a similar tripartite structure comprised of an N-terminal glucosyltransferase domain, a C-terminal receptor binding domain, and a small hydrophobic span possibly involved in toxin translocation (6). This recombinant TcdA only contains the enzymatic domain. Both TcdA and TcdB also have potassium-dependent UDP-Glc hydrolase activity, which is essentially glucosyltransferase activity with water as the acceptor molecule (7). Under same conditions, UDP-glucose hydrolysis by TcdB occurs at a rate about
5-fold greater than that of TcdA.
- Wilkins, T.D. and Lyerly, D.M. (2003) J. Clin. Microbiol 41:53.
- Kyne, L. et al. (2002) Clin. Infect. Dis. 34:346.
- Voth, D.E. and Ballard, J.D. (2005) Clin. Microbiol. Rev. 18:247.
- Chaves-Olarte, E. et al. (1996) J. Biol. Chem. 271:6925.
- Just I, et al. (1995) J. Biol. Chem. 270:13932.
- Hammond, G.A. and Johnson, J.L. (1995) Microb. Pathog. 19:203.
- Ciesla, W.P. Jr. and Bobak, D.A. (1998) J. Biol. Chem. 273:16021.
Citation for Recombinant C. difficile Toxin A/TcdA Protein, CF
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
1 Citation: Showing 1 - 1
-
Modulation of colonic immunometabolic responses during Clostridioides difficile infection ameliorates disease severity and inflammation
Authors: Tubau-Juni, N;Bassaganya-Riera, J;Leber, AJ;Alva, SS;Baker, R;Hontecillas, R;
Scientific reports
Species: Human
Sample Types: Whole Cells
Applications: Bioassay
FAQs
No product specific FAQs exist for this product, however you may
View all Proteins and Enzyme FAQsReviews for Recombinant C. difficile Toxin A/TcdA Protein, CF
There are currently no reviews for this product. Be the first to review Recombinant C. difficile Toxin A/TcdA Protein, CF and earn rewards!
Have you used Recombinant C. difficile Toxin A/TcdA Protein, CF?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image